Q1: Furen Pharmaceutical (SHA: 600871) reported the following accounting data in 2018 and 2017 respectively: In million RMB Cash and cash equivalents Total interest-bearing debt Interest revenue Interest expense Current asset Total asset Stockholders' equity 2017 1,656 3,407 7 135.8 4,437 9,880 4,660 2018 1,816 3,595 6.1 183 4,472 10,717 5,467 In July 2018, Furen announced that it's unable to pay the 62 million RMB dividend due to insufficient cash on hand.
Q1: Furen Pharmaceutical (SHA: 600871) reported the following accounting data in 2018 and 2017 respectively: In million RMB Cash and cash equivalents Total interest-bearing debt Interest revenue Interest expense Current asset Total asset Stockholders' equity 2017 1,656 3,407 7 135.8 4,437 9,880 4,660 2018 1,816 3,595 6.1 183 4,472 10,717 5,467 In July 2018, Furen announced that it's unable to pay the 62 million RMB dividend due to insufficient cash on hand.
Chapter9: Projecting Financial Statements
Section: Chapter Questions
Problem 3bM
Related questions
Question
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 3 steps
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.Recommended textbooks for you